Skip to main content

MoneyWorks4Me

Solara Active Pharma Sciences sells 100% stake in SeQuent Penems

26 Apr 2024 Evaluate

Solara Active Pharma Sciences has completed sale of 100% shareholding in SeQuent Penems to M/s. Symbio Generrics India on April 25, 2024. Hence, SeQuent Penems ceased to be a subsidiary of the Company. The board of directors of the company at its meeting held on March 25, 2024 approved the same.  

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1786.05
Dr. Reddys Labs. 1379.00
Cipla 1411.95
Lupin 1999.00
Zydus Lifesciences 1196.05
View more..